Movone (Dexibuprofen)

Dexibuprofen acts as an NSAID that alleviates symptoms associated with inflammatory pathways.

• Pain: Provides analgesic relief by decreasing prostaglandin‑mediated nociception.
• Inflammation: Reduces swelling and tissue inflammation in musculoskeletal conditions.
• Fever: Lowers elevated body temperature by inhibiting pyrogenic prostaglandin synthesis.

• Dexibuprofen exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, pain signalling, and fever generation throughout the body. The inhibition is reversible and occurs at therapeutic concentrations, leading to decreased formation of prostaglandin E2 and other mediators involved in vascular permeability, leukocyte infiltration, and sensitisation of nociceptors.

Dexibuprofen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Gastrointestinal discomfort: dyspepsia, abdominal pain, or nausea.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Skin rash or mild itching.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding.
• Renal impairment or acute kidney injury.
• Hepatic enzyme elevation or liver injury.
• Severe hypersensitivity reactions, including Stevens‑Johnson syndrome.
• Cardiovascular events such as myocardial infarction or stroke.

When using Dexibuprofen, several precautions should be observed to minimise risk.

• Assess renal function: evaluate kidney status before initiating therapy in patients with renal disease.
• Monitor hepatic health: avoid use in patients with active liver disease or elevated transaminases.
• Use lowest effective dose: limit duration to the shortest period necessary to control symptoms.
• Caution in cardiovascular risk: consider alternative therapy for patients with history of heart failure or thrombotic events.
• Store at room temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Dexibuprofen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• Corticosteroids: heightened risk of ulceration.
• ACE inhibitors or ARBs: possible reduction in renal function.
• Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely)

• Diuretics: may impair renal clearance.
• Methotrexate: reduced elimination leading to toxicity.
• SSRIs or SNRIs: potential for increased bleeding.
• Oral hypoglycemics: possible alteration of blood glucose control.